Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT06582017 |
Title | Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma |
Recruitment | Recruiting |
Gender | both |
Phase | Phase I |
Variant Requirements | No |
Sponsors | Nammi Therapeutics Inc |
Indications | |
Therapies | |
Age Groups: | senior | adult |
Covered Countries | USA |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
University of Southern California | NOT_YET_RECRUITING | Los Angeles | California | 90033 | United States | Details |
Cedars-Sanai Medical Center - Samuel Oschin Comprehensive Cancer | NOT_YET_RECRUITING | Los Angeles | California | 90048 | United States | Details |
Hoag Memorial Hospital Presbyterian | NOT_YET_RECRUITING | Newport | California | 92663 | United States | Details |
Sarah Cannon Research Institute - Denver DDU | NOT_YET_RECRUITING | Denver | Colorado | 80218 | United States | Details |
Emory University - Winship Cancer Institute | NOT_YET_RECRUITING | Atlanta | Georgia | 30322 | United States | Details |
New York Cancer & Blood Specialists | NOT_YET_RECRUITING | New York | New York | 11967 | United States | Details |
University of Rochester - Wilmot Cancer Institute | NOT_YET_RECRUITING | Rochester | New York | 14642 | United States | Details |
START San Antonio | RECRUITING | San Antonio | Texas | 78229 | United States | Details |